Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
This is a highly effective vaccine suitable for children and should find utility in endemic regions and as a traveler's vaccine. More
The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Feb 2011 - 36 pages - $1,000
Oct 2009 - 17 pages - $500
Apr 2011 - 105 pages - $3,500
Nov 2011 - 7 pages - $3,835
Jun 2006 - 1458 pages - $2,495
Oct 2011 - 150 pages - $3,500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us